Studies related to Creatinine and L-Carnitine

Blood Pressure And Metabolic Effects Of Acetyl-l-Carnitine In Type 2 Diabetes: DIABASI Randomized Controlled Trial

Effect None
Values mg/dL Mean and SD. Placebo: before 0.94 ± 0.2, after 0.95 ± 0.2. Carnitine: before 0.93 ± 0.2, after 0.93 ± 0.2.
Trial Design Randomized trial
Trial Length n/a
Number of Subjects 229
Sex Both Genders
Notes for this study:
In a randomized, double-blind, placebo-controled trial, 229 participants with hypertension and dyslipidemic type 2 diabetes took 1000 mg of acetyl-l-carnitine twice daily in addition to simvastatin, or only simvastatin for 6 months.

The primary outcome was systolic blood pressure, and there wasn't an apparent benefit, nor for diastolic blood pressure, weight, HbA1c, insulin, insulin sensitivity, glucose disposal rate, lipid profile, or kidney function.

There weren't notable differences in adverse events.

Full details on all 2 studies are available to Examine Members. Try out the Examine Membership with a 14-day free trial.

Already a Member? Log in now to access.